HSV Peptides
Overview
Herpes simplex virus (HSV) is a lytic virus and one of the most prevalent viral infections in humans. While manageable with nucleoside analog antivirals, HSV establishes lifelong latency and can reactivate, driving continued research into novel antiviral strategies. HSV-derived peptides — sourced from viral glycoproteins, capsid assembly proteins, and the UL26 protease — provide essential tools for studying viral entry, assembly, and inhibition.
Key Features
- Includes HSV-1 glycoprotein gB (497-507), UL26 open reading frame peptides, and HSV-gB2 (498-505)
- Nle253-substituted and C-terminal amidated variants for enhanced stability
- Purity ≥95% verified by HPLC with batch-specific COA
Product Specifications
| Parameter | Specification |
|---|---|
| Purity | ≥95% or ≥98% (HPLC verified) |
| Form | Lyophilized powder |
| Storage | -20°C, desiccated, protected from light |
| Research Use Only | Yes |
| Purity | ≥95% or ≥98% (HPLC verified) |
| Form | Lyophilized powder |
| Storage | -20°C, desiccated, protected from light |
| Research Use Only | Yes |